255 related articles for article (PubMed ID: 15721563)
21. High accumulation of platinum-DNA adducts in strial marginal cells of the cochlea is an early event in cisplatin but not carboplatin ototoxicity.
Thomas JP; Lautermann J; Liedert B; Seiler F; Thomale J
Mol Pharmacol; 2006 Jul; 70(1):23-9. PubMed ID: 16569706
[TBL] [Abstract][Full Text] [Related]
22. Transtympanic administration of short interfering (si)RNA for the NOX3 isoform of NADPH oxidase protects against cisplatin-induced hearing loss in the rat.
Mukherjea D; Jajoo S; Kaur T; Sheehan KE; Ramkumar V; Rybak LP
Antioxid Redox Signal; 2010 Sep; 13(5):589-98. PubMed ID: 20214492
[TBL] [Abstract][Full Text] [Related]
23. The role of antioxidants in protection from ototoxic drugs.
Sergi B; Fetoni AR; Ferraresi A; Troiani D; Azzena GB; Paludetti G; Maurizi M
Acta Otolaryngol Suppl; 2004 May; (552):42-5. PubMed ID: 15219046
[TBL] [Abstract][Full Text] [Related]
24. Ototoxicity: therapeutic opportunities.
Rybak LP; Whitworth CA
Drug Discov Today; 2005 Oct; 10(19):1313-21. PubMed ID: 16214676
[TBL] [Abstract][Full Text] [Related]
25. Future opportunities in preventing cisplatin induced ototoxicity.
van den Berg JH; Beijnen JH; Balm AJ; Schellens JH
Cancer Treat Rev; 2006 Aug; 32(5):390-7. PubMed ID: 16781082
[TBL] [Abstract][Full Text] [Related]
26. Ebselen prevents noise-induced excitotoxicity and temporary threshold shift.
Yamasoba T; Pourbakht A; Sakamoto T; Suzuki M
Neurosci Lett; 2005 Jun; 380(3):234-8. PubMed ID: 15862892
[TBL] [Abstract][Full Text] [Related]
27. Mechanisms of cisplatin-induced ototoxicity and prevention.
Rybak LP; Whitworth CA; Mukherjea D; Ramkumar V
Hear Res; 2007 Apr; 226(1-2):157-67. PubMed ID: 17113254
[TBL] [Abstract][Full Text] [Related]
28. A novel synthetic compound, 3-amino-3-(4-fluoro-phenyl)-1H-quinoline-2,4-dione, inhibits cisplatin-induced hearing loss by the suppression of reactive oxygen species: in vitro and in vivo study.
Shin YS; Song SJ; Kang SU; Hwang HS; Choi JW; Lee BH; Jung YS; Kim CH
Neuroscience; 2013 Mar; 232():1-12. PubMed ID: 23246618
[TBL] [Abstract][Full Text] [Related]
29. The cochlear targets of cisplatin: an electrophysiological and morphological time-sequence study.
van Ruijven MW; de Groot JC; Klis SF; Smoorenburg GF
Hear Res; 2005 Jul; 205(1-2):241-8. PubMed ID: 15953532
[TBL] [Abstract][Full Text] [Related]
30. Cisplatin-induced ototoxicity: the effect of pigmentation and inhibitory agents.
Schweitzer VG
Laryngoscope; 1993 Apr; 103(4 Pt 2):1-52. PubMed ID: 8464301
[TBL] [Abstract][Full Text] [Related]
31. Oral ethanol potentiates the loss of outer hair cells in cisplatin-exposed rats.
Madnani D; Li G; Frenz CM; Frenz DA
Otolaryngol Head Neck Surg; 2007 Aug; 137(2):327-31. PubMed ID: 17666265
[TBL] [Abstract][Full Text] [Related]
32. Cisplatin ototoxicity involves organ of Corti, stria vascularis and spiral ganglion: modulation by alphaMSH and ORG 2766.
Hamers FP; Wijbenga J; Wolters FL; Klis SF; Sluyter S; Smoorenburg GF
Audiol Neurootol; 2003; 8(6):305-15. PubMed ID: 14566101
[TBL] [Abstract][Full Text] [Related]
33. Prevention of noise- and drug-induced hearing loss with D-methionine.
Campbell KC; Meech RP; Klemens JJ; Gerberi MT; Dyrstad SS; Larsen DL; Mitchell DL; El-Azizi M; Verhulst SJ; Hughes LF
Hear Res; 2007 Apr; 226(1-2):92-103. PubMed ID: 17224251
[TBL] [Abstract][Full Text] [Related]
34. Assessing cisplatin-induced ototoxicity and otoprotection in whole organ culture of the mouse inner ear in simulated microgravity.
Tropitzsch A; Arnold H; Bassiouni M; Müller A; Eckhard A; Müller M; Löwenheim H
Toxicol Lett; 2014 Jun; 227(3):203-12. PubMed ID: 24709139
[TBL] [Abstract][Full Text] [Related]
35. Vitamin E reduces cisplatin ototoxicity.
Kalkanis JG; Whitworth C; Rybak LP
Laryngoscope; 2004 Mar; 114(3):538-42. PubMed ID: 15091231
[TBL] [Abstract][Full Text] [Related]
36. [Research progress on mechanism of cisplatin ototoxicity and protective agents against the ototoxic effects].
Liao YJ; Tang H
Sheng Li Ke Xue Jin Zhan; 2003 Jul; 34(3):266-9. PubMed ID: 14628479
[No Abstract] [Full Text] [Related]
37. Light microscopy study of cisplatin-induced ototoxicity in rats.
de Freitas MR; de Castro Brito GA; de Carvalho JV; Gomes RM; Barreto Martins MJ; de Albuquerque Ribeiro R
J Laryngol Otol; 2009 Jun; 123(6):590-7. PubMed ID: 19144244
[TBL] [Abstract][Full Text] [Related]
38. Time sequence of degeneration pattern in the guinea pig cochlea during cisplatin administration. A quantitative histological study.
van Ruijven MW; de Groot JC; Smoorenburg GF
Hear Res; 2004 Nov; 197(1-2):44-54. PubMed ID: 15504603
[TBL] [Abstract][Full Text] [Related]
39. Neuroprotective effects of ebselen are associated with the regulation of Bcl-2 and Bax proteins in cultured mouse cortical neurons.
Xu JH; Hu HT; Liu Y; Qian YH; Liu ZH; Tan QR; Zhang ZJ
Neurosci Lett; 2006 May; 399(3):210-4. PubMed ID: 16513270
[TBL] [Abstract][Full Text] [Related]
40. Beneficial effects of Ebselen on corrosive esophageal burns of rats.
Ocakci A; Coskun O; Tumkaya L; Kanter M; Gurel A; Hosnuter M; Uzun L
Int J Pediatr Otorhinolaryngol; 2006 Jan; 70(1):45-52. PubMed ID: 15979162
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
